Cerulean Pharma reported $-9163000 in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agile Therapeutics AGRX:US $ -16.77M 0.86M
Arrowhead Research ARWR:US $ -63.37M 33.45M
Biocept BIOC:US $ 0.43M 2.26M
Brainstorm Cell Therapeutics BCLI:US $ -5.34M 0.93M
Immunogen IMGN:US $ -37.34M 6.6M
Johnson & Johnson JNJ:US $ 8058M 282M
Macrogenics MGNX:US $ -52.89M 12.95M
Nektar Therapeutics NKTR:US $ -129.59M 4.43M